Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ionis Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
IONS
Nasdaq
8731
https://www.ionispharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ionis Pharmaceuticals Inc
The Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
- May 9th, 2024 11:34 am
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript
- May 8th, 2024 7:15 pm
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
- May 8th, 2024 2:39 pm
Ionis Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
- May 8th, 2024 11:32 am
Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
- May 8th, 2024 9:20 am
Ionis Pharmaceuticals Inc (IONS) Q1 2024 Earnings Call Transcript Highlights: Key Developments ...
- May 8th, 2024 7:40 am
Ionis Pharmaceuticals (IONS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- May 7th, 2024 1:30 pm
Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates
- May 7th, 2024 12:10 pm
Ionis reports first quarter 2024 financial results
- May 7th, 2024 11:00 am
Wall Street's Insights Into Key Metrics Ahead of Ionis Pharmaceuticals (IONS) Q1 Earnings
- May 6th, 2024 1:15 pm
4D Molecular Therapeutics, Inc. (FDMT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
- May 1st, 2024 2:01 pm
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
- Apr 30th, 2024 2:00 pm
Ionis Publishes 2023 Corporate Responsibility Report
- Apr 25th, 2024 11:00 am
Ionis to hold first quarter 2024 financial results webcast
- Apr 23rd, 2024 11:05 am
Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome
- Apr 7th, 2024 1:48 pm
Ionis to present at upcoming investor conferences
- Apr 1st, 2024 11:05 am
Ionis to hold olezarsen Phase 3 data webcast
- Mar 28th, 2024 11:05 am
Can Ionis' (IONS) Wholly-Owned Drugs Cut Dependency on Collabs?
- Mar 25th, 2024 1:09 pm
Positive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 2024 American College of Cardiology (ACC) annual meeting
- Mar 25th, 2024 12:18 pm
Ionis Pharmaceuticals (IONS) Down 2.8% Since Last Earnings Report: Can It Rebound?
- Mar 22nd, 2024 3:30 pm
Scroll